Menu

US Officials Order DNA Tests to Reunite Migrant Families

The goal is to expedite the time it takes to bring families together, but immigration advocates say the tests raise concerns about how the government will use the data.

Jul 6, 2018
Ashley Yeager

In an effort to reunite nearly 3,000 migrant children with their parents, the US Department of Health and Human Services will be conducting DNA tests via a cheek swab, NBC News reported yesterday (July 5). 

The matches must be made by July 10 for children younger than five years and by July 26 for children ages 5–17, according to a federal judge in the Southern District of California. Traditional methods, such as reviewing birth certificates, to verify the parents of the children would take too long, according to Health and Human Services (HHS) Secretary Alex Azar. Jonathan White, assistant secretary for preparedness and response at HHS, tells NBC News the results of the DNA tests would not be used for anything other than to match children with their parents.

Immigration advocates aren’t convinced by the promise and are voicing concerns about what the government might do with the data once they are collected, such as tracking where immigrants are moving, according to BBC News. There are also concerns about how a child can consent to such a test.

“They’re essentially solving one civil rights issue with another—it’s a gross violation of human rights,” Jennifer Falcon, communications director for the immigrants rights group RAICES, tells NBC News in a separate story posted yesterday. “These are minors with no legal guardian to be able to [advise them] on their legal right, not to mention they’re so young how can they consent to their personal information being used in this way?”

The call for DNA tests also raises questions about whether the immigrants were properly processed when they were originally detained at the border. “When people are detained they are fingerprinted already so why do they need DNA swabs if these people went through the proper intake process when they were detained?” Falcon says.

Emergency physician Alicia Hart, who is treating children in detention centers, tells CNN that information on migrant children doesn’t exist. “Unfortunately, records haven’t been kept,” she says. “DNA’s probably going to be our only way of [identifying parents] and ensuring these kids get back to a safe home.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.